Rohan Mitra

Employment

• Sanofi India
  2017 - Present
• Novartis Healthcare Ltd
  2014 - 2017
• Indegene Lifesystems Pvt Ltd
  2012 - 2014

Education

• National Institute of Mental Health and Neurosciences PhD
  2008 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Expression and Purification of OsVDAC4
  Methods in Enzymology 2015 DOI: 10.1016/bs.mie.2014.12.019
  +Save
• BAY 61-3606, CDKi, and Sodium Butyrate Treatments Modulate p53 Protein Level and Its Site-Specific Phosphorylation in Human Vestibular Schwannomas In Vitro
  Journal of Cancer Research 2014 DOI: 10.1155/2014/249354
  +Save
• Personalized Genome, Current Status, and the Future of Pharmacogenomics
  Omics for Personalized Medicine 2013 DOI: 10.1007/978-81-322-1184-6_2
  +Save
• Sodium butyrate modulates pRb phosphorylation and induces cell death in human vestibular schwannomas in vitro
  2012
  +Save
• Bacterial Expression, Purification and Characterization of a Rice Voltage-Dependent, Anion-Selective Channel Isoform, OsVDAC4
  The Journal of Membrane Biology 2011 DOI: 10.1007/s00232-011-9399-x
  +Save
• Molecular Genetics of Human Cancers
  OMICS 2011 DOI: 10.1201/b11482-14
  +Save
• BAY 61-3606, CDKi, and sodium butyrate treatments alter gene expression in human vestibular schwannomas and cause cell death in vitro
  Ecancermedicalscience DOI: 10.3332/ecancer.2012.285
  +Save